| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 132, 235-240, Copyright © 1993 by Endocrine Society
ARTICLES |
DL Lu, H Peegel, SM Mosier and KM Menon
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor 48109-0278.
Previous studies have demonstrated that ligand-induced down-regulation of the LH/hCG receptor in rat corpus luteum results in a loss of ligand- binding activity and a parallel decline in steady state levels of receptor mRNA. The purpose of the present study was to determine whether this loss of receptor mRNA during receptor down-regulation is due to inhibition of transcription or increased degradation of the receptor mRNA. To differentiate between these two possibilities, nuclear run-off assays were performed to study transcription rates of nuclei isolated from control and hCG down-regulated rat ovaries. A 750- mer LH/hCG receptor cDNA probe, spanning the carboxy-terminal region of the peptide and the 3'-untranslated region of the receptor cDNA, was constructed by polymerase chain reaction. RNA transcripts were synthesized from existing nuclear RNA from control and down-regulated nuclei and hybridized to the receptor cDNA probe immobilized on nylon membranes and subjected to autoradiography. Hybridization to actin cDNA was also run alongside as a control. The results of run-off transcription analysis indicated that during down-regulation, the transcription rates of LH/hCG receptor mRNA are not decreased compared to those in saline-treated controls. Although no decrease in the transcription rates of the receptor mRNA was seen in the down-regulated state, the steady state levels of the receptor mRNA showed a decline when assayed by either solution hybridization or Northern blot analysis. Furthermore, hCG induced down-regulation appears to increase the transcriptional activity of the nuclei. Estimates of steady state LH/hCG receptor mRNA turnover rates indicate that the half-life of the message in down-regulated ovaries is markedly reduced compared to that in the control. It is concluded that the loss of steady state LH/hCG receptor mRNA is not due to a decrease in transcription, but probably represents an increased degradation of the receptor mRNA.
This article has been cited by other articles:
![]() |
L. Wang, A. K. Nair, and K. M. J. Menon Ribonucleic Acid Binding Protein-Mediated Regulation of Luteinizing Hormone Receptor Expression in Granulosa Cells: Relationship to Sterol Metabolism Mol. Endocrinol., September 1, 2007; 21(9): 2233 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Emerald, Y. Chen, T. Zhu, Z. Zhu, K.-O. Lee, P. D. Gluckman, and P. E. Lobie {alpha}CP1 Mediates Stabilization of hTERT mRNA by Autocrine Human Growth Hormone J. Biol. Chem., January 5, 2007; 282(1): 680 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair, H. Peegel, and K. M. J. Menon The Role of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor-Specific mRNA Binding Protein in Regulating Receptor Expression in Human Ovarian Granulosa Cells J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2239 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair and K. M. J. Menon Regulation of Luteinizing Hormone Receptor Expression: EVIDENCE OF TRANSLATIONAL SUPPRESSION IN VITRO BY A HORMONALLY REGULATED mRNA-BINDING PROTEIN AND ITS ENDOGENOUS ASSOCIATION WITH LUTEINIZING HORMONE RECEPTOR mRNA IN THE OVARY J. Biol. Chem., December 30, 2005; 280(52): 42809 - 42816. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang and K. M. J. Menon Regulation of Luteinizing Hormone/Chorionic Gonadotropin Receptor Messenger Ribonucleic Acid Expression in the Rat Ovary: Relationship to Cholesterol Metabolism Endocrinology, January 1, 2005; 146(1): 423 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair and K. M. J. Menon Isolation and Characterization of a Novel trans-Factor for Luteinizing Hormone Receptor mRNA from Ovary J. Biol. Chem., April 9, 2004; 279(15): 14937 - 14944. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M.J. Menon, U. M. Munshi, C. L. Clouser, and A. K. Nair Regulation of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Expression: A Perspective Biol Reprod, April 1, 2004; 70(4): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yang, Z. M. Lei, and Ch. V. Rao The Central Role of Human Chorionic Gonadotropin in the Formation of Human Placental Syncytium Endocrinology, March 1, 2003; 144(3): 1108 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair, J. C. Kash, H. Peegel, and K. M. J. Menon Post-transcriptional Regulation of Luteinizing Hormone Receptor mRNA in the Ovary by a Novel mRNA-binding Protein J. Biol. Chem., June 7, 2002; 277(24): 21468 - 21473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guo, L. Savage, K. D. Sarge, and O.-K. Park-Sarge Gonadotropins Decrease Estrogen Receptor-{beta} Messenger Ribonucleic Acid Stability in Rat Granulosa Cells Endocrinology, June 1, 2001; 142(6): 2230 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, H. Peegel, and K. M. J. Menon Regulation of High Density Lipoprotein Receptor Messenger Ribonucleic Acid Expression and Cholesterol Transport in Theca-Interstitial Cells by Insulin and Human Chorionic Gonadotropin Endocrinology, January 1, 2001; 142(1): 174 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, L. K. Curtiss, R. L. Wade, and C. A. Dyer An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17{alpha}-hydroxylase, C17–20 lyase J. Lipid Res., December 1, 1998; 39(12): 2406 - 2414. [Abstract] [Full Text] |
||||
![]() |
F.-P. Zhang, T. El-Hafnawy, and I. Huhtaniemi Regulation of Luteinizing Hormone Receptor Gene Expression by Insulin-Like Growth Factor-I in an Immortalized Murine Leydig Tumor Cell Line (BLT-1) Biol Reprod, November 1, 1998; 59(5): 1116 - 1123. [Abstract] [Full Text] |
||||
![]() |
J. C. Kash and K. M. J. Menon Identification of a Hormonally Regulated Luteinizing Hormone/Human Chorionic Gonadotropin Receptor mRNA Binding Protein. INCREASED mRNA BINDING DURING RECEPTOR DOWN-REGULATION J. Biol. Chem., April 24, 1998; 273(17): 10658 - 10664. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |